San Francisco Bay Area biotech stories.
Tuesday, May 10, 2011
Impax starts testing Restless Legs Syndrome drug
Impax Laboratories Inc. started a Phase I test of a treatment aimed at Restless Legs Syndrome, and it also filed an application for the drug with regulators.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)